S F Williams - Concepedia

Author

S F Williams

University of Chicago

Also Known As

S F Williams, S. F. Williams, S.F. WILLIAMS, S.F. Williams, Stephanie F. Williams

Publications

854

Citations

H-Index

Concepts

All Affiliations

University of Chicago Baxter (United States)University of Chicago Medical Center

About

S F Williams is an author at University of Chicago specializing in medicine, hematology, and cellular therapies.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	273
2	Health Sciences	3	3	57
3	Allergy	1	1	24
4	Allergy Medicine	1	1	24
5	Biomedical Engineering	1	1	112

S F Williams

Publications

836

Citations

H-Index

Page 1

	Year	Citations
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. Karen H. Antman, Philip A. Rowlings, William P. Vaughan, Journal of Clinical Oncology	1997	327
High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report. S F Williams, Theresa Gilewski, Rosemarie Mick, Journal of Clinical Oncology	1992	133
High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. S F Williams, Rosemarie Mick, Richard K. Desser, Journal of Clinical Oncology Cell TherapyBreast OncologyAdjuvant ChemotherapyPathologyPhase Ii Study	1989	112
Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. S F Williams, Jacob D. Bitran, Jdm Richards, PubMed	1990	85
High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: Pattern of failure and implications for involved-field radiotherapy Arno J. Mundt, S F Williams, Dennis E. Hallahan International Journal of Radiation OncologyBiologyPhysics Lymphoid NeoplasiaCell TherapyAggressive Non-hodgkinRadiation TherapyMedicine	1997	41
Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma. Richard L. Schilsky, S F Williams, John E. Ultmann, Journal of Clinical Oncology Sequential Hydroxyurea-cytarabine ChemotherapyImmunologyPharmacotherapyHu 500Immunotherapy	1987	36
HYPERSENSITIVITY REACTION TO HIGH‐DOSE CYTARABINE S F Williams, Richard A. Larson British Journal of Haematology Drug HypersensitivityAllergyAllergy MedicineMedicinePharmacotherapy	1989	24
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation Shivani Singhal, Leo I. Gordon, Martin S. Tallman, Bone Marrow Transplantation Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationHematology	2006	21
The CD34+ cell concentration in peripheral blood predicts CD34+ cell yield in the leukapheresis product Kristi Hollingsworth, Todd M. Zimmerman, Theodore Karrison, Cytotherapy Hematological MalignancyCd34+ Cell ConcentrationLeukapheresis ProductImmunologyHematology	1999	18
Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation. Robert B. Geller, S Myers, S M Devine, PubMed	1992	18

Page 1